Visterra Strikes Deal With Pfizer, Presents Strong Data For Flu Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
The start-up supplied few details about its arrangement with its Big Pharma partner, but receives cash as it prepares to take a promising influenza therapy into the clinic.